サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1559694

前立腺肥大症治療器の世界市場

Benign Prostatic Hyperplasia Devices

出版日
ページ情報
英文 192 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
前立腺肥大症治療器の世界市場
出版日: 2024年09月24日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

前立腺肥大症治療器の世界市場は2030年までに8億1,650万米ドルに達する見込み

2023年に5億8,280万米ドルと推定される前立腺肥大症治療器の世界市場は、2030年には8億1,650万米ドルに達し、分析期間2023-2030年のCAGRは4.9%で成長すると予測されます。本レポートで分析したセグメントの1つである病院の最終用途は、CAGR 5.3%を記録し、分析期間終了までに4億9,690万米ドルに達すると予測されます。泌尿器科クリニックの最終用途セグメントの成長率は、分析期間中CAGR 4.4%と推定されます。

米国市場は推定1億5,850万米ドル、中国はCAGR4.7％で成長すると予測

米国の前立腺肥大症治療器市場は、2023年に1億5,850万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億2,950万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは4.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.7%と4.1%と予測されています。欧州では、ドイツがCAGR 4.9%で成長すると予測されています。

世界の前立腺肥大症治療器市場- 主要動向と促進要因のまとめ

現代の治療において前立腺肥大症治療器が果たす役割とは？

前立腺肥大症（BPH）治療機器は、前立腺肥大症の管理に不可欠なツールであり、高齢男性によく見られるこの症状に伴う症状や合併症を大幅に軽減する低侵襲ソリューションを提供します。これらの機器は、従来の外科的アプローチに代わるものであり、より的を絞った患者に優しい治療を可能にします。BPH治療機器には、経尿道的前立腺切除術（TURP）機器、レーザー治療システム、前立腺ステント、水蒸気療法や前立腺尿道リフト（PUL）システムなどの新しい治療法など、さまざまな技術が含まれます。尿道を塞いでいる余分な前立腺組織を除去または再配置することで、これらの機器は尿流を改善し、頻尿や尿閉などの関連症状を緩和します。このような先進的な装置のイントロダクションより、男性が利用できる選択肢は広がり、特定の健康ニーズや回復目標に沿った、より個別化された治療戦略が可能になりました。

技術革新はどのようにBPH治療機器の効果を高めているのか？

技術革新はBPH治療機器の有効性と安全性を大幅に向上させ、患者の予後改善と幅広い治療選択肢をもたらしました。ホルミウムレーザー前立腺核出術（HoLEP）のようなレーザー治療システムは、精密なレーザー技術を活用し、最小限の侵襲で余分な組織を除去することで、従来の手術法に伴うリスクを軽減しています。水蒸気を利用して前立腺組織を縮小させる水蒸気療法のような革新的な治療法は、非侵襲的で長期的に優れた結果をもたらします。さらに、前立腺尿道リフト（PUL）システムの開発は、前立腺組織を切ったり除去したりすることなく物理的に再配置する方法を提供することで、前立腺肥大症治療に革命をもたらし、性機能を維持し、より早い回復を保証しています。このような進歩は、BPH治療の成功率を向上させるだけでなく、より身近で患者の生活への支障を少なくし、より多くの男性がこのような革新的な解決策を求めるよう促しています。

なぜヘルスケアシステム全体でBPH治療機器の需要が高まっているのか？

BPH治療機器に対する需要は、いくつかの重要な動向によりヘルスケアシステム全体で急速に増加しています。世界の高齢者人口の増加によりBPHの罹患率が高くなり、効果的で低侵襲な治療オプションに対するニーズが高まっています。今日の患者はより多くの情報を得ており、回復時間が短くリスクが低い外来手術を好むことが多いため、BPH治療機器は特に魅力的です。BPHの症状に対する認識が高まり、先進的な治療オプションが利用できるようになったことで、より多くの男性が早期に医師の診察を受けるようになり、BPH治療機器の需要が高まっています。さらに、コストを削減しながら患者の転帰を改善することに焦点を当てた価値ベースのヘルスケアモデルへのシフトが、医療提供者を高品質で効率的なケアを提供できるBPH治療機器の導入へと駆り立てています。これらの要因が、現代の泌尿器科医療に不可欠な存在となりつつあるBPH機器の利用拡大に寄与しています。

BPH機器市場の成長を促進する主な要因とは？

BPH治療機器市場の成長は、高齢化社会におけるBPHの有病率の上昇や、治療を必要とする患者層の拡大など、いくつかの要因によってもたらされています。医療技術の開発、特にレーザー治療や前立腺尿道リフトシステムといった侵襲性の低い手技の開発も、より安全で効果的な治療選択肢を提供することで市場の成長を後押ししています。入院期間と医療費を削減できる外来治療への嗜好が高まっていることも、これらの機器の採用をさらに後押ししています。さらに、BPHとその生活の質への影響に対する意識の高まりにより、早期介入を求める男性が増加しているため、革新的なBPH治療機器の需要が高まっています。こうした動向の継続的な進展に伴い、BPH機器市場は、継続的な技術革新と、効果的で患者に優しい治療ソリューションに対する需要の高まりに支えられ、力強い成長を遂げると予想されます。

調査対象企業の例（注目の38社）

  • Biolitec, Inc.
  • Boston Scientific Corporation
  • Lumenis Be Ltd.
  • Olympus Corporation
  • UK MEDS DIRECT Limited
  • Urologix, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP10675

Global Benign Prostatic Hyperplasia Devices Market to Reach US$816.5 Million by 2030

The global market for Benign Prostatic Hyperplasia Devices estimated at US$582.8 Million in the year 2023, is expected to reach US$816.5 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$496.9 Million by the end of the analysis period. Growth in the Urology Clinics End-Use segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$158.5 Million While China is Forecast to Grow at 4.7% CAGR

The Benign Prostatic Hyperplasia Devices market in the U.S. is estimated at US$158.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$129.5 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.7% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Benign Prostatic Hyperplasia Devices Market - Key Trends and Drivers Summarized

What Role Do Benign Prostatic Hyperplasia Devices Play in Modern Treatment?

Benign Prostatic Hyperplasia (BPH) devices are essential tools in the management of prostate enlargement, offering minimally invasive solutions that significantly reduce the symptoms and complications associated with this common condition in aging men. These devices provide alternatives to traditional surgical approaches, enabling more targeted and patient-friendly treatments. BPH devices include a range of technologies such as transurethral resection of the prostate (TURP) instruments, laser therapy systems, prostatic stents, and newer treatments like water vapor therapy and prostatic urethral lift (PUL) systems. By either removing or repositioning excess prostate tissue that blocks the urethra, these devices improve urinary flow and alleviate related symptoms like frequent urination and urinary retention. The introduction of these advanced devices has expanded the options available to men, allowing for more personalized treatment strategies that align with their specific health needs and recovery goals.

How Are Technological Innovations Enhancing BPH Device Effectiveness?

Technological innovations have significantly enhanced the effectiveness and safety of BPH devices, leading to better patient outcomes and broader treatment options. Laser therapy systems, such as holmium laser enucleation of the prostate (HoLEP), leverage precision laser technology to remove excess tissue with minimal invasiveness, reducing the risks associated with traditional surgical methods. Innovations like water vapor therapy, which utilizes steam to shrink prostate tissue, offer a non-invasive alternative with excellent long-term results. Additionally, the development of prostatic urethral lift (PUL) systems has revolutionized BPH treatment by providing a method to physically reposition the prostate tissue without cutting or removing it, thus preserving sexual function and ensuring quicker recovery. These advancements are not only improving the success rates of BPH treatments but also making them more accessible and less disruptive to patients' lives, encouraging more men to seek out these innovative solutions.

Why Is There Increasing Demand for BPH Devices Across Healthcare Systems?

The demand for BPH devices is rapidly increasing across healthcare systems due to several key trends. The growing elderly population worldwide is leading to a higher incidence of BPH, creating a greater need for effective, minimally invasive treatment options. Patients today are more informed and often prefer outpatient procedures that offer shorter recovery times and lower risks, which makes BPH devices particularly appealing. Increased awareness about BPH symptoms and the availability of advanced treatment options are prompting more men to seek medical attention earlier, thereby boosting the demand for these devices. Additionally, the shift towards value-based healthcare models, which focus on improving patient outcomes while reducing costs, is driving healthcare providers to adopt BPH devices that can deliver high-quality, efficient care. These factors are contributing to the growing utilization of BPH devices, which are becoming an integral part of modern urological care.

What Are the Key Factors Driving the Growth of the BPH Devices Market?

The growth in the BPH devices market is driven by several factors, including the rising prevalence of BPH among the aging population, which is expanding the pool of patients requiring treatment. Advances in medical technology, particularly in the development of less invasive procedures such as laser therapies and prostatic urethral lift systems, are also fueling market growth by offering safer, more effective treatment options. The increasing preference for outpatient care, which reduces hospitalization time and healthcare costs, is further boosting the adoption of these devices. Additionally, heightened awareness of BPH and its impact on quality of life is leading more men to seek early intervention, thus driving demand for innovative BPH devices. As these trends continue to evolve, the BPH devices market is expected to experience robust growth, supported by ongoing technological innovations and the rising demand for effective, patient-friendly treatment solutions.

Select Competitors (Total 38 Featured) -

  • Biolitec, Inc.
  • Boston Scientific Corporation
  • Lumenis Be Ltd.
  • Olympus Corporation
  • UK MEDS DIRECT Limited
  • Urologix, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Benign Prostatic Hyperplasia Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of BPH Among Aging Males Spurs Growth in BPH Devices Market
    • Increasing Preference for Outpatient Treatments Expands Addressable Market for BPH Devices
    • Growing Demand for Effective Long-Term Management Strengthens the Business Case for BPH Devices
    • Expansion of Urology Clinics and Specialized Centers Drives Adoption of BPH Devices
    • Advancements in Laser and Thermal Therapies Generate New Opportunities in BPH Devices Market
    • Push for Shorter Recovery Times Drives Demand for Minimally Invasive BPH Devices
    • Growing Use of BPH Devices in Geriatric Care Spurs Innovation in Treatment Technologies
    • Increasing Importance of Post-Treatment Monitoring Accelerates Adoption of Advanced BPH Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for TURP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for TURP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for TURP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Laser Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Laser Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Laser Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Other Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Urology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Urology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Urology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Benign Prostatic Hyperplasia Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Benign Prostatic Hyperplasia Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Benign Prostatic Hyperplasia Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030

IV. COMPETITION